Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors

F Linkov, R Edwards, J Balk, Z Yurkovetsky… - European Journal of …, 2008 - Elsevier
PURPOSE: Endometrial carcinoma is the most common cancer of the lower female genital
tract in Europe and the United States. Faced with the growing incidence of endometrial …

CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding

NU Kumar, MG Sridhar, K Srilatha, S Habebullah - African health sciences, 2018 - ajol.info
Background: Incidence of endometrial cancer in India is increasing due to lifestyle changes
and obesity. As 5 year survival rate of cancer confined to uterus is good, there is need for …

[HTML][HTML] Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study

C Reijnen, NCM Visser, JC Kasius… - Journal of …, 2019 - synapse.koreamed.org
Objectives The global obesity epidemic has great impact on the prevalence of low-grade
endometrial carcinoma. The preoperative tumor serum marker cancer antigen 125 (CA-125) …

Tissue and serum CA125 expression in endometrial cancer

S Ginath, J Menczer, Y Fintsi, E Ben-Shem… - International Journal of …, 2002 - ijgc.bmj.com
Serum CA125 is elevated in some endometrial cancer patients. The purpose of the present
study was to assess the correlation between the presence of CA125 in endometrial cancer …

Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study

HS Kim, CY Park, JM Lee, JK Lee, CH Cho, SM Kim… - Gynecologic …, 2010 - Elsevier
OBJECTIVE: To evaluate the role of serum CA-125 levels for preoperative counseling in
endometrioid endometrial cancer (EEC). METHODS: We reviewed 413 patients with EEC …

Validation of serum biomarkers for detection of early-and late-stage endometrial cancer

G Farias-Eisner, F Su, T Robbins, J Kotlerman… - American journal of …, 2010 - Elsevier
OBJECTIVE: The objective of this study was to determine the efficacy of 3 previously
described ovarian cancer serum biomarkers (apolipoprotein-1 [ApoA-I], prealbumin [TTR] …

Clinical significance of serum interleukin‐31 and interleukin‐33 levels in patients of endometrial cancer: a case control study

X Zeng, Z Zhang, QQ Gao, YY Wang, XZ Yu… - Disease …, 2016 - Wiley Online Library
Aims. Previous evidence has proved that interleukin‐31 (IL‐31) and interleukin‐33 (IL‐33)
can be potential markers in some cancers' formulation. We aimed to determine the potential …

Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer

A Chao, YH Tang, CH Lai, CJ Chang, SC Chang… - Gynecologic …, 2013 - Elsevier
OBJECTIVE: It is not clear whether the prognostic value of pretreatment serum CA125 levels
is independent or through association with other clinicopathological features in endometrial …

Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray

MA Bidus, JI Risinger, GVR Chandramouli… - Clinical Cancer …, 2006 - AACR
Purpose: To characterize the gene expression profiles of endometrioid endometrial cancers
associated with lymph node metastasis in an effort to identify genes associated with …

[HTML][HTML] Serum biomarkers for early detection of gynecologic cancers

Y Ueda, T Enomoto, T Kimura, T Miyatake, K Yoshino… - Cancers, 2010 - mdpi.com
Ovarian, endometrial, and cervical cancers are three of the most common malignancies of
the female reproductive organs. CA 125, historically the most reliable serum marker for …